including BinaxNOW and ID NOW rapid tests. By late 2021, Abbott was producing more than 50 million tests per month. The company made $7.7 billion from the sale of global testing supplies in 2021 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results